Reports
Sale
Global Ascites Market Share, Size, Analysis, Report, Demand, Growth, Forecast: By Treatment: Medicinal Therapy, Surgery, Paracentesis, Others; By Diagnosis: Ultrasound, CT Scan, MRI, Blood Test, Laparoscopy, Angiography, Others; By Route of Administration: Oral, Parenteral, Others; By End User; Regional Analysis; Supplier Landscape; 2024-2032
Global Ascites Market Outlook
The global ascites market size attained a value of USD 2.07 billion in 2023. The major drivers of the industry, such as the increasing prevalence of the disease, rising disposable incomes, growing health consciousness, rapid urbanisation, and growing R&D activities, are expected to aid the market growth. The market is anticipated to grow at a CAGR of 4.3% during the forecast period of 2024-2032 to attain a value of USD 3.02 billion by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The North American and the European Market for Ascites to Be Aided by the Advancements in Healthcare Industry
North America and Europe are expected to be the key regional markets for ascites treatment. This dominance can be correlated to the highly developed healthcare infrastructure and higher awareness about ascites and its subsequent diagnosis and treatment methods. The availability of skilled and knowledgeable healthcare professionals in developed countries is also aiding the growth in these regions.
The Asia Pacific market is projected to witness a swift growth owing to the rising literacy rate and improving economic conditions. Rapid development in the healthcare industry in countries, such as China, India, and Japan, are aiding the Asia Pacific market growth. The ascites industry in Latin American nations, such as Brazil, Argentina, and Mexico, is anticipated to have a steady growth owing to the availability of advanced healthcare facilities.
Ascites: Market Segmentation
Accumulation of fluid in the peritoneal cavity (i.e., the space between the lining of abdominal organs and abdomen) is known as ascites. It is often caused by scarring of the liver due to cirrhosis. Some of the other causes of ascites may include liver damage, hepatitis B or C, and alcohol consumption. If not treated appropriately, ascites could lead to kidney failure, peritonitis, blood sepsis, and ultimately death.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Based on type, the market can be classified into:
- Transudative
- Exudative
By diagnosis, the market is segmented into:
- Angiography
- CT Scan
- Laparoscopy
- Ultrasound
- Others
Based on treatment, the market is categorised into:
- Medicinal Therapy
- Diuretics
- Antibiotics
- Liver Transplantation
- Paracentesis
- Others
The EMR report looks into the regional markets of ascites like North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Rising Prevalence of the Liver Cirrhosis to Bolster the Market Growth of Ascites
The global market for ascites is being driven by the growing awareness about the disease. Ascites are one of the main complications of liver cirrhosis. The rising prevalence of liver cirrhosis across the globe due to the increasing consumption of alcohol is driving the market. The increasing healthcare activities and campaigns regarding the necessity to address ascites are aiding the market. Moreover, the rising investments in research and development projects are adding to the market growth. Highly developed healthcare infrastructure and the availability of skilled professionals are aiding the market in mature nations. On the other hand, the market in emerging nations is showing great potential owing to the improving economic conditions and rising literacy rates. Furthermore, rising disposable incomes and increasing awareness about the available treatment methods are expected to provide an impetus for the market growth in the forecast period.
Key Industry Players in the Global Ascites Market
The report presents a detailed analysis of the following key players in the global ascites market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
- Becton, Dickinson, and Company
- BioVie Inc.
- Sequana Medical NV
- Sanofi Inc.
- Others
The comprehensive report looks into the macro and micro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Treatment |
|
| Breakup by Diagnosis |
|
| Breakup by Route of Administration |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Ascites Overview
3.1 Guidelines and Stages
3.2 Pathophysiology
3.3 Screening and Diagnosis
3.4 Treatment Pathway
4 Patient Profile
4.1 Patient Profile Overview
4.2 Patient Psychology and Emotional Impact Factors
4.3 Risk Assessment and Treatment Success Rate
5 Ascites Epidemiology Analysis
5.1 Epidemiology Overview (2016-2031)
5.2 North America Ascites Epidemiology (2016-2031)
5.3 Europe Ascites Epidemiology (2016-2031)
5.4 Asia-Pacific Ascites Epidemiology (2016-2031)
5.5 Latin America Ascites Epidemiology (2016-2031)
5.6 Middle East & Africa Ascites Epidemiology (2016-2031)
6 Global Ascites Market Overview
6.1 Global Ascites Market Historical Value (2017-2023)
6.2 Global Ascites Market Forecast Value (2024-2032)
7 Global Ascites Market Landscape
7.1 Ascites: Developers Landscape
7.1.1 Analysis by Year of Establishment
7.1.2 Analysis by Company Size
7.1.3 Analysis by Region
7.2 Ascites: Product Landscape
7.2.1 Analysis by Treatment
7.2.2 Analysis by Diagnosis
7.2.3 Analysis by Route of Administration
7.2.4 Analysis by End User
8 Ascites Challenges and Unmet Needs
8.1 Treatment Pathway Challenges
8.2 Compliance and Drop-Out Analysis
8.3 Awareness and Prevention Gaps
9 Cost of Treatment
10 Global Ascites Market Dynamics
10.1 Market Drivers and Constraints
10.2 SWOT Analysis
10.3 Porter’s Five Forces Model
10.4 Key Demand Indicators
10.5 Key Price Indicators
10.6 Industry Events, Initiatives, and Trends
10.7 Value Chain Analysis
11 Global Ascites Market Segmentation
11.1 Global Ascites Market by Treatment
11.1.1 Market Overview
11.1.2 Medicinal Therapy
11.1.2.1 Diuretics
11.1.2.2 Antibiotics
11.1.3 Surgery
11.1.4 Paracentesis
11.1.5 Others
11.2 Global Ascites Market by Diagnosis
11.2.1 Market Overview
11.2.2 Ultrasound
11.2.3 CT Scan
11.2.4 MRI
11.2.5 Blood Test
11.2.6 Laparoscopy
11.2.7 Angiography
11.2.8 Others
11.3 Global Ascites Market by Route of Administration
11.3.1 Market Overview
11.3.2 Oral
11.3.3 Parenteral
11.3.4 Others
11.4 Global Ascites Market by End User
11.4.1 Market Overview
11.4.2 Hospitals & Clinics
11.4.3 Research and Academic Laboratories
11.4.4 Others
11.5 Global Ascites Market by Region
11.5.1 Market Overview
11.5.2 North America
11.5.3 Europe
11.5.4 Asia Pacific
11.5.5 Latin America
11.5.6 Middle East and Africa
12 North America Ascites Market
12.1 Market Share by Country
12.2 United States of America
12.3 Canada
13 Europe Ascites Market
13.1 Market Share by Country
13.2 United Kingdom
13.3 Germany
13.4 France
13.5 Italy
13.6 Others
14 Asia Pacific Ascites Market
14.1 Market Share by Country
14.2 China
14.3 Japan
14.4 India
14.5 ASEAN
14.6 Australia
14.7 Others
15 Latin America Ascites Market
15.1 Market Share by Country
15.2 Brazil
15.3 Argentina
15.4 Mexico
15.5 Others
16 Middle East and Africa Ascites Market
16.1 Market Share by Country
16.2 Saudi Arabia
16.3 United Arab Emirates
16.4 Nigeria
16.5 South Africa
16.6 Others
17 Regulatory Framework
17.1 Regulatory Overview
17.1.1 US FDA
17.1.2 EU EMA
17.1.3 INDIA CDSCO
17.1.4 JAPAN PMDA
17.1.5 Others
18 Patent Analysis
18.1 Analysis by Type of Patent
18.2 Analysis by Publication year
18.3 Analysis by Issuing Authority
18.4 Analysis by Patent Age
18.5 Analysis by CPC Analysis
18.6 Analysis by Patent Valuation
18.7 Analysis by Key Players
19 Grants Analysis
19.1 Analysis by year
19.2 Analysis by Amount Awarded
19.3 Analysis by Issuing Authority
19.4 Analysis by Grant Application
19.5 Analysis by Funding Institute
19.6 Analysis by NIH Departments
19.7 Analysis by Recipient Organization
20 Clinical Trials Analysis
20.1 Analysis by Trial Registration Year
20.2 Analysis by Trial Status
20.3 Analysis by Trial Phase
20.4 Analysis by Therapeutic Area
20.5 Analysis by Geography
21 Funding and Investment Analysis
21.1 Analysis by Funding Instances
21.2 Analysis by Type of Funding
21.3 Analysis by Funding Amount
21.4 Analysis by Leading Players
21.5 Analysis by Leading Investors
21.6 Analysis by Geography
22 Partnership and Collaborations Analysis
22.1 Analysis by Partnership Instances
22.2 Analysis by Type of Partnership
22.3 Analysis by Leading Players
22.4 Analysis by Geography
23 Supplier Landscape
23.1 Becton, Dickinson and Company
23.1.1 Financial Analysis
23.1.2 Product Portfolio
23.1.3 Demographic Reach and Achievements
23.1.4 Mergers and Acquisitions
23.1.5 Certifications
23.2 BioVie Inc.
23.2.1 Financial Analysis
23.2.2 Product Portfolio
23.2.3 Demographic Reach and Achievements
23.2.4 Mergers and Acquisitions
23.2.5 Certifications
23.3 Sequana Medical NV
23.3.1 Financial Analysis
23.3.2 Product Portfolio
23.3.3 Demographic Reach and Achievements
23.3.4 Mergers and Acquisitions
23.3.5 Certifications
23.4 Sanofi Inc.
23.4.1 Financial Analysis
23.4.2 Product Portfolio
23.4.3 Demographic Reach and Achievements
23.4.4 Mergers and Acquisitions
23.4.5 Certifications
23.5 F. Hoffmann-La Roche Ltd.
23.5.1 Financial Analysis
23.5.2 Product Portfolio
23.5.3 Demographic Reach and Achievements
23.5.4 Mergers and Acquisitions
23.5.5 Certifications
23.6 Teva Pharmaceutical Industries Ltd.
23.6.1 Financial Analysis
23.6.2 Product Portfolio
23.6.3 Demographic Reach and Achievements
23.6.4 Mergers and Acquisitions
23.6.5 Certifications
23.7 Novartis AG
23.7.1 Financial Analysis
23.7.2 Product Portfolio
23.7.3 Demographic Reach and Achievements
23.7.4 Mergers and Acquisitions
23.7.5 Certifications
23.8 Sun Pharmaceutical Industries Ltd.
23.8.1 Financial Analysis
23.8.2 Product Portfolio
23.8.3 Demographic Reach and Achievements
23.8.4 Mergers and Acquisitions
23.8.5 Certifications
23.9 Merck & Co., Inc.
23.9.1 Financial Analysis
23.9.2 Product Portfolio
23.9.3 Demographic Reach and Achievements
23.9.4 Mergers and Acquisitions
23.9.5 Certifications
23.10 WOCKHARDT
23.10.1 Financial Analysis
23.10.2 Product Portfolio
23.10.3 Demographic Reach and Achievements
23.10.4 Mergers and Acquisitions
23.10.5 Certifications
24 Ascites - Distribution Model (Additional Insight)
24.1 Overview
24.2 Potential Distributors
24.3 Key Parameters for Distribution Partner Assessment
25 Key Opinion Leaders (KOL) Insights (Additional Insight)
26 Company Competitiveness Analysis (Additional Insight)
26.1 Very Small Companies
26.2 Small Companies
26.3 Mid-Sized Companies
26.4 Large Companies
26.5 Very Large Companies
27 Payment Methods (Additional Insight)
27.1 Government Funded
27.2 Private Insurance
27.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
In 2023, the global market for ascites reached a value of USD 2.07 billion.
The market is anticipated to grow at a CAGR of 4.3% during the forecast period of 2024-2032 to reach a value of USD 3.02 billion by 2032.
The major drivers of the industry, such as the increasing prevalence of the disease, rising disposable incomes, growing health consciousness, rapid urbanisation, and growing R&D activities, are expected to aid the market growth.
The key trend in the market is the growing healthcare investments by governmental and non-governmental players.
The major regional markets for ascites are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
The major types of ascites in the market are transudative and exudative.
The leading treatment types in the market are medicinal therapy, liver transplantation, and paracentesis, among others.
The major diagnosis methods in the market are angiography, CT scan, laparoscopy, ultrasound, and others.
The key players in the market include Becton, Dickinson and Company, BioVie Inc., Sequana Medical NV, and Sanofi Inc., among others.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$ 3499
$1999
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5999
$2999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 7999
$3999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 9999
$5999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER